These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24394867)

  • 61. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acoustic voice assessment in Parkinson's disease patients submitted to posteroventral pallidotomy.
    Mourão LF; Aguiar PM; Ferraz FA; Behlau MS; Ferraz HB
    Arq Neuropsiquiatr; 2005 Mar; 63(1):20-5. PubMed ID: 15830059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Speech rate in Parkinson's disease: A controlled study.
    Martínez-Sánchez F; Meilán JJ; Carro J; Gómez Íñiguez C; Millian-Morell L; Pujante Valverde IM; López-Alburquerque T; López DE
    Neurologia; 2016 Sep; 31(7):466-72. PubMed ID: 25660139
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Postural sway and effect of levodopa in early Parkinson's disease.
    Beuter A; Hernández R; Rigal R; Modolo J; Blanchet PJ
    Can J Neurol Sci; 2008 Mar; 35(1):65-8. PubMed ID: 18380279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Working memory in Parkinson's disease patients: clinical features and response to levodopa.
    Beato R; Levy R; Pillon B; Vidal C; du Montcel ST; Deweer B; Bonnet AM; Houeto JL; Dubois B; Cardoso F
    Arq Neuropsiquiatr; 2008 Jun; 66(2A):147-51. PubMed ID: 18545772
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spiral analysis in subjects with Parkinson's disease before and after levodopa treatment: a new protocol with stereophotogrammetric systems.
    Galli M; Vimercati SL; Manetti E; Cimolin V; Albertini G; De Pandis MF
    J Appl Biomater Funct Mater; 2014 Sep; 12(2):e107-12. PubMed ID: 22798231
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Micturition disturbances in Parkinson's disease. Clinical and urodynamic evaluation].
    Krygowska-Wajs A; Weglarz W; Szczudlik ZD
    Neurol Neurochir Pol; 2002; 36(1):25-32. PubMed ID: 12053613
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Verbal and visual memory in patients with early Parkinson's disease: effect of levodopa.
    Singh S; Behari M
    Neurol India; 2006 Mar; 54(1):33-7. PubMed ID: 16679640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Color vision impairment in Parkinson's disease.
    Piro A; Tagarelli A; Nicoletti G; Fletcher R; Quattrone A
    J Parkinsons Dis; 2014; 4(3):317-9. PubMed ID: 24796233
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of utterance rate and length on the spatiotemporal index in Parkinson's disease.
    Chu SY; Barlow SM; Lee J; Wang J
    Int J Speech Lang Pathol; 2020 Apr; 22(2):141-151. PubMed ID: 31213093
    [No Abstract]   [Full Text] [Related]  

  • 71. Monitoring the Effect of Levodopa Using Sustained Phonemes in Parkinson's Disease Patients.
    Motin MA; Pah ND; Kumar DK
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083746
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Beneficial effect of levodopa therapy on stooped posture in Parkinson's disease.
    Benninger F; Khlebtovsky A; Roditi Y; Keret O; Steiner I; Melamed E; Djaldetti R
    Gait Posture; 2015 Sep; 42(3):263-8. PubMed ID: 26055804
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Levodopa addiction and factitious disorder in a patient with idiopathic Parkinson's disease.
    Zaharna M; Pandya M
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352g.e11-352.e12. PubMed ID: 20686151
    [No Abstract]   [Full Text] [Related]  

  • 74. Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease.
    Hood AJ; Amador SC; Cain AE; Briand KA; Al-Refai AH; Schiess MC; Sereno AB
    J Neurol Neurosurg Psychiatry; 2007 Jun; 78(6):565-70. PubMed ID: 17178817
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease.
    Gallena S; Smith PJ; Zeffiro T; Ludlow CL
    J Speech Lang Hear Res; 2001 Dec; 44(6):1284-99. PubMed ID: 11776365
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mood response to levodopa infusion in early Parkinson's disease.
    Maricle RA; Valentine RJ; Carter J; Nutt JG
    Neurology; 1998 Jun; 50(6):1890-2. PubMed ID: 9633754
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relative fundamental frequency during vocal onset and offset in older speakers with and without Parkinson's disease.
    Stepp CE
    J Acoust Soc Am; 2013 Mar; 133(3):1637-43. PubMed ID: 23464033
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa.
    Racette BA; Gokden MS; Tychsen LS; Perlmutter JS
    Strabismus; 1999 Sep; 7(3):169-74. PubMed ID: 10520242
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [F0 characteristics in Parkinsonian speech: Contrast between the effect of hypodopaminergy due to Parkinson's disease and that of the therapeutic delivery of L-Dopa].
    Ghio A; Robert D; Grigoli C; Mas M; Delooze C; Mercier C; Viallet F
    Rev Laryngol Otol Rhinol (Bord); 2014; 135(2):63-70. PubMed ID: 26521344
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of L-Dopa administration on pursuit ocular movements in suspected Parkinson's disease.
    Marino S; Lanzafame P; Sessa E; Bramanti A; Bramanti P
    Neurol Sci; 2010 Jun; 31(3):381-5. PubMed ID: 19924505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.